On September 3, 2026 Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, reported that senior management will participate in the following investor conferences in September 2026:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor Global Healthcare Conference: Fireside chat on Wednesday, September 9, 2026 at 2:45 p.m. ET
H.C. Wainwright 28th Annual Global Investment Conference: Company presentation available on Monday, September 14, 2026
A webcast of each event will be accessible by visiting the "Events" section on the "Investors" page of Quince’s website at www.quincetx.com. A replay of the webcasts will be available following the presentation and will be archived for at least 30 days.
(Press release, Quince Therapeutics, SEP 3, 2026, View Source [SID1234670574])